Health Ministry Confirms Availability of Medicines for Chronic Diseases, Cancer, Diabetes, Hypertension and Infectious Illnesses

The Ministry of Health and Social Services has announced the delivery and distribution of 33 critically needed pharmaceutical items as part of ongoing efforts to restore medicine availability across Namibia’s public health facilities.
In its fourth public update on pharmaceutical stock deliveries, issued on 2 July 2026, the ministry said the latest shipments are aimed at addressing immediate shortages while supporting longer-term plans to strengthen the country’s medicine supply chain through bulk procurement.
According to the ministry, the medicines were received and distributed between 18 June and 1 July 2026, with priority given to essential treatments that have experienced stock shortages in recent months.
The newly delivered supplies include a wide range of medicines used to treat chronic diseases, infectious illnesses, cancer, diabetes and hypertension, as well as vaccines, nutritional products and emergency medical supplies.
Among the medicines received are anti-cancer drugs such as Cyclophosphamide, Cytarabine and Thioguanine, antibiotics including Erythromycin, Metronidazole and Dapsone, diabetes treatments such as insulin and Metformin, as well as Amlodipine for high blood pressure management.
The shipment also includes the Measles and Rubella vaccine, contraceptive implants, intravenous fluids, thyroid medication, children’s nutritional feeds, eye ointments, anti-allergy medication, anti-vomiting medicines, skin treatments, vitamins and Paracetamol syrup.
The ministry said the deliveries form part of broader interventions to improve the availability of essential medicines throughout the public healthcare system while ensuring that patients continue receiving the treatment they require.
It further noted that additional consignments of essential medicines are expected to arrive in the coming weeks as procurement and supply chain improvement measures continue.
The Ministry of Health and Social Services said it will continue monitoring medicine stock levels, strengthen supply chain management and work closely with stakeholders to address pharmaceutical supply challenges across the country.
As part of its commitment to transparency, the ministry announced that it will continue issuing public updates on the availability of essential medicines and health commodities every two weeks.
Acting Executive Director Dr. Theo-Ben Kandetu said the ministry remains committed to transparent communication and ensuring equitable access to quality healthcare services for all Namibians.




